Heparin as a therapy for COVID-19: current evidence and future possibilities
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heparin as a therapy for COVID-19: current evidence and future possibilities
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 319, Issue 2, Pages L211-L217
Publisher
American Physiological Society
Online
2020-06-10
DOI
10.1152/ajplung.00199.2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells
- (2020) Xu Li et al. Journal of Inflammation-London
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alveolar heparan sulfate shedding impedes recovery from bleomycin-induced lung injury
- (2020) W. B. LaRivière et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
- (2020) Ishan Paranjpe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A Comment
- (2020) Christopher D. Barrett et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
- (2020) Thomas J. Oxley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure
- (2020) Katelyn Arnold et al. Science Translational Medicine
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- Circulating heparan sulfate fragments mediate septic cognitive dysfunction
- (2019) Joseph A. Hippensteel et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
- (2019) Jean-Louis Vincent et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients
- (2018) Zhenguo Zhai et al. CHEST
- Entry of Human Coronavirus NL63 into the Cell
- (2017) Aleksandra Milewska et al. JOURNAL OF VIROLOGY
- Targeting heparin and heparan sulfate protein interactions
- (2017) Ryan J. Weiss et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Circulating Heparan Sulfate Fragments Attenuate Histone-Induced Lung Injury Independently of Histone Binding
- (2017) Yanlin Zhang et al. SHOCK
- Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?
- (2016) Hiran Bandeshe et al. JOURNAL OF CRITICAL CARE
- Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice
- (2016) S. Antoniak et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Regulation of Alveolar Procoagulant Activity and Permeability in Direct Acute Lung Injury by Lung Epithelial Tissue Factor
- (2015) Ciara M. Shaver et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
- (2012) Eric P Schmidt et al. NATURE MEDICINE
- Drotrecogin Alfa (Activated) in Adults with Septic Shock
- (2012) V. Marco Ranieri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress
- (2012) Julie A Bastarache et al. THORAX
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
- (2011) Jianshe Lang et al. PLoS One
- Evaluation of Bleeding Risk in Patients Exposed to Therapeutic Unfractionated or Low-Molecular-Weight Heparin: A Cohort Study in the Context of a Quality Improvement Initiative
- (2010) B. Cossette et al. ANNALS OF PHARMACOTHERAPY
- Venous thromboembolism in critically ill patients
- (2008) Mark Williams et al. THROMBOSIS AND HAEMOSTASIS
- The anti-inflammatory effects of heparin and related compounds
- (2007) Edward Young THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search